UPLC–QTOF/MS-based metabolomic profiling of Lespedeza species for marker selection and monoamine oxidase inhibitory activity
Abstract Monoamine oxidases (MAO)-A and MAO-B are key enzymes involved in the regulation of monoamine neurotransmitters and are closely associated with various neuropsychiatric and neurodegenerative disorders. In this study, the MAO-A and MAO-B inhibitory activities of methanol extracts from Korean native Lespedeza species were compared and related to metabolite profiles using ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC–QTOF/MS)-based metabolomics combined with in silico prediction of central nervous system distribution. Among the tested species ( L. maximowiczii , L. thunbergii , L. tomentosa , and L. cyrtobotrya ), L. cyrtobotrya exhibited the strongest inhibitory activity, with the stem extract showing the most pronounced effect (MAO-A 80.33% and MAO-B 91.91% inhibition at 20 µg/mL). Untargeted metabolomic analysis tentatively identified 65 secondary metabolites, and multivariate statistical analyses including principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) clearly discriminated L. cyrtobotrya from the other species and further separated its leaf and stem extracts. Marker selection based on the OPLS-DA S-plot and subsequent box plot analysis ( p < 0.05) indicated that non-prenylated flavonoids were enriched in the leaf, whereas prenylated flavonoids such as diplacone, sanggenol A, and xanthoangelol were relatively enriched in the stem. SwissADME and pkCSM-based in silico predictions indicated diverse physicochemical and central nervous system distribution properties among the selected metabolites (log P − 0.24–5.30; log BB − 2.41–−0.57; log PS − 5.24–−1.95), with stem-enriched prenylated flavonoids showing relatively higher lipophilicity. Overall, this integrated bioactivity-metabolomics approach identifies L. cyrtobotrya stem as a promising source of MAO-modulating metabolites, including diplacone and sanggenol A, whose moderate MAO inhibitory activities were directly confirmed in the present study.
Authors
- Hyung Won Ryu (ORCID: https://orcid.org/0000-0001-5291-3942)
- Sei‐Ryang Oh (ORCID: https://orcid.org/0000-0002-9769-4779)
- Sung‐Kyun Ko (ORCID: https://orcid.org/0000-0002-8202-1205)
- Hyoung‐Geun Kim (ORCID: https://orcid.org/0000-0002-2867-1063)
- Dongho Lee (ORCID: https://orcid.org/0000-0003-4379-814X)
- Su‐Yeon Lee (ORCID: https://orcid.org/0009-0002-1471-2204)
- Su-Ah Lee
- Doo-Young Kim
- Jung-Hee Kim
- Ji-Hong Kim
Institutions
- Korea University (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Applied Biological Chemistry
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1186/s13765-026-01152-8
- Primary Topic
- Phytochemistry and Biological Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00